A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple intravenous doses of BWC0977 when administered to healthy adult volunteers.
Age: Healthy male or female 18 to 55 years of age, inclusive, at time of consent [+10]
1) Pregnancy and Lactation: Women who are pregnant and/or lactating. 2) Signific... [+2]